DUBLIN–(BUSINESS WIRE)–The “North
America Metagenomics Market to 2027- Regional Analysis and Forecasts by
Product, Application and Country” report has been added to ResearchAndMarkets.com’s
offering.
The North America Metagenomics market is expected to reach US$ 106.9 Mn
in 2027 from US$ 55.2 Mn in 2018. The market is estimated to grow with a
CAGR of 8% from 2018-2027.
The growth of the market is driven by the factors such as increasing
investments in the metagenomics and diverse applications of
metagenomics, in the North America region. Whereas, high cost associated
with metagenomics is likely to have a negative impact on the growth of
the market in the coming years.
Metagenomics is the upcoming field of the biotechnology and the
extensive researches are being conducted in the labs across the world.
Several clinical labs in United States, have already undertaken the
considerable lengths to upgrade and validate a wide range of protocols
for agnostically detecting viral, bacterial, fungal and eukaryotic
parasite nucleic acid in different specimens of patient to benefit in
diagnosis for particularly intractable cases.
The extensive research need is pushing the venture capitals or academic
medical centers to subsidize the prices for the metagenomics testing.
They help to conduct researches to carry out testing in US$ 2000 – US$
3000 per sample.
Major market players such as Illumina based in California have
introduced breakthrough technologies that have enabled in the cost and
time reduction in the sequencing. For instance, Illumina’s NovaSeq 6000
Sequencing System releases groundbreaking innovations. The system
enables accessible throughput and flexibility for virtually any
sequencing method, genome and scale of project.
Owing to factor that the cost of the metagenomics is been subsidize by
the venture capitalists and the innovative technology by the market
leaders that enables the access to the metagenomics studies are likely
to propel the growth of the market in the forecast period.
US is anticipated to lead the adoptions of Metagenomics across the North
American region through the forecast period. The major players
headquartered in the US are also focused towards developing innovative
and novel products and bringing them into market, which is also one of
the major factors driving the growth of US in the North America
metagenomics market.
Moreover, the companies are significantly investing under research and
development to come-up with medical products that are derived from
natural microbial sources. For instance, in August 2018, Genentech and
Lodo initiated a US$ 1 Bn project to develop unique, natural products
from the microbial DNA found in soil. Under the collaboration, Genentech
will use Lodo’s metagenome-prospecting platform to identify novel small
molecules with the potential for treating disease.
Key Topics Covered
Part 1. Introduction
Part 2. North America Metagenomics Market – Key Takeaways
Part 3. North America Metagenomics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.3 Pest Analysis
Part 4. North America Metagenomics Market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Investments in the Field of Metagenomics
4.1.2 Benefits of Metagenomics Over Traditional Methods
4.1.3 Diverse Potential Applications of Metagenomics
4.2 Key Market Restraints
4.2.1 High Cost Associated With Metagenomics
4.3 Key Market Opportunities
4.3.1 Precision Metagenomic Analysis in Personalised Medicine
4.4 Key Market Trends
4.4.1 Growing Trend of Molecular-Based Approaches
4.5 Impact Analysis
Part 5. Metagenomics Market – North America Analysis
5.1 North America Metagenomics Market Revenue Forecasts and Analysis
5.2 Market Positioning
5.3 Performance of Key Players
– Illumina Inc.
– Qiagen
5.4 Expert Opinions
Part 6. North America Metagenomics Market Analysis – by Product
6.1 Overview
6.2 North America Metagenomics Market, by Product, 2018 & 2027 (%)
6.3 North America Metagenomics Market Revenue and Forecasts To 2027, by
Product (US$ Mn)
6.4 Instruments & Software Market
6.5 Consumables Market
Part 7. North America Metagenomics Market Analysis – by Application
7.1 Overview
7.2 North America Metagenomics Market, by Application, 2018 & 2027 (%)
7.3 Clinical Diagnostic Market
7.4 Drug Discovery Metagenomics Market
7.5 Others Market
Part 8. North America Metagenomics Market Revenue and Forecasts To 2027
8.1 Overview
8.2 North America Metagenomics Market Revenue and Forecasts To 2027, by
Country (%)
8.3 Us Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
8.4 Canada Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
8.5 Mexico Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
Part 9. Metagenomics Market -Industry Landscape
9.1 Overview
9.2 Growth Strategies In the Metagenomics Market, 2015-2018
9.3 Organic Developments
9.4 Organic Growth Strategies In the Metagenomics Market, 2015-2018
9.5 Product Launch
9.6 Product Approval
9.7 Expansion & Others
9.8 Inorganic Developments
9.9 Inorganic Growth Strategies In the Metagenomics Market, 2015-2018
9.10 Acquisitions
9.11 Agreements
9.12 Partnership & Collaboration
Part 10. Metagenomics Market – Key Company Profiles
10.1 Merck KGaA
10.2 Thermo Fisher Scientific Inc.
10.3 Agilent Technologies Inc.
10.4 Qiagen
10.5 Bio-Rad Laboratories Inc.
10.6 Perkin Elmer Inc.
10.7 Illumina Inc.
10.8 F. Hoffmann-La Roche Ltd.
10.9 Oxford Nanopore Technologies Ltd.
10.10 Pacific Bioscience of California Inc.
For more information about this report visit https://www.researchandmarkets.com/r/l7akrl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics